High-Frequency Electrosurgery for Rhinophyma: A Three-Case Series


Kandemir E., Yiğitoğlu G., YAŞAR Ş., Baysak S.

Turkish Journal of Dermatology, cilt.20, sa.3, ss.141-145, 2026 (ESCI, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 3
  • Basım Tarihi: 2026
  • Doi Numarası: 10.4274/tjd.galenos.2026.92259
  • Dergi Adı: Turkish Journal of Dermatology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Central & Eastern European Academic Source (CEEAS), CINAHL, EMBASE, TR DİZİN (ULAKBİM), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
  • Sayfa Sayıları: ss.141-145
  • Anahtar Kelimeler: Dermatologic surgical procedures, electrosurgery, radiofrequency, rhinophyma, rosacea
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Rhinophyma is a progressive dermatologic condition characterized by hypertrophy of sebaceous glands and connective tissue, leading to nasal deformity and significant psychosocial impact. We present three male patients with rhinophyma treated using high-frequency electrosurgery. All patients presented with progressive nasal enlargement causing cosmetic concern, and one case was associated with inflammatory lesions and discharge. High-frequency electrosurgery was performed under local anesthesia using a radiofrequency device, enabling precise tissue debulking with simultaneous coagulation. Postoperative healing was achieved within 2–4 weeks in all patients, with no major complications. At follow-up, all patients demonstrated satisfactory cosmetic outcomes, and only one patient developed minimal scarring that did not affect overall satisfaction. High-frequency electrosurgery provided effective removal of hypertrophic tissue with minimal collateral damage and rapid recovery. These findings suggest that high-frequency electrosurgery appears to be a practical, efficient, and relatively cost-effective treatment option in selected patients with rhinophyma. Further studies with larger patient groups and longer follow-up periods are needed to better define long-term outcomes and recurrence rates.